Wellcon Eradicate (Fluralaner) 112.5mg Tablet for Very Small Dogs

This lowest-strength formulation in the Eradicate series provides rapid parasite kill (fleas within 2 hours, ticks within 12 hours) via blood meal uptake, offering convenient quarterly dosing without the mess of topicals or monthly compliance failures common with spot-on treatments.

• Composition : Fluralaner 112.5mg (isoxazoline ectoparasiticide).
  Highly palatable beef/liver-flavored chewable base.

Indications :

• Flea infestation control (Ctenocephalides spp.).
  
• Tick prevention (Ixodes ricinus, Dermacentor spp.).
  
• Demodex mites (monthly dosing).
  
• Sarcoptes scabiei (generalized demodicosis).

Features :

• Single dose eliminates existing infestation + prevents reinfestation for 3 months.
  
• Kills fleas before reproduction (breaks life cycle).
  
• Rapid tick mortality prevents Lyme disease/Anaplasma transmission.
  
• Safe for puppies ≥8 weeks, MDR1 mutants, breeding dogs.

Directions for Use:

• Dosage: 1 tablet for dogs 2-4.5kg body weight every 12 weeks.
  

• Administer directly by mouth or with food; ensure complete consumption.
  

• Veterinary prescription required; no bathing restrictions.

Disclosure:

A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.

Disclaimer:

Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.